Global Investor Forum Contact

Mirjam Mol

CEO, Pivot Park

Session

11:30 - 12:45 hours
From innovation to implementation

Mirjam Mol-Arts was appointed on October 1, 2014 as CEO of Pivot Pivot Park and Pivot Park Screening Centre. Mirjam is an honors graduate in medicine from the University of Utrecht. She has a sound medical scientific background and has worked in various hospitals in the Netherlands until 1989, when she switched to pharma to the clinical development group in Solvay Duphar. In 1997 Mirjam started as Clinical Development Director at Organon and in 2001 she became head of the Women's Health Programme. Since 2011, she was part of the Dutch management of MSD, which merged with Schering-Plough, worldwide in 2009 and was chair of the local management of MSD in Oss. She was closely involved in the creation of Pivot Park and was part of the Task Force Life Sciences Park Oss. Mirjam is also a member of the Steering Committee of the Dutch Topsector Life Sciences & Health (Health Holland) and a member of the board of Health Valley.

Since January 1st 2018 Mirjam is Senior Vice President Global Clinical and Non-Clinical development at Ferring in Kopenhagen.

Abstract

Pivot Park: hotspot for pharmaceutical innovation
Pivot Park is an inspiring campus for (open) innovation in the life sciences with a focus on pharmaceutical Research, Development and Production. It is the perfect place for start-ups and existing companies to accelerate, grow and succeed.
Pivot Park was launched in February 2012 as an initiative of pharmaceutical company MSD in close collaboration with five public partners after closure of the MSD Oss R&D group.
‘Pivot’ means axis or central point, and that’s exactly the role that Pivot Park wants to fulfil on a daily basis for dynamic life sciences companies. How? By offering state-of-the-art core facilities and infrastructure, the flexibility to deliver customised work to ambitious entrepreneurs in the life sciences sector and an inspiring community. Several companies at Pivot Park were successful, starting of as a small company and scaled-up to over 25 and some of them over 50 employees, and delivering new treatment options to patients.
How can we, especially on a national level, facilitate entrepreneurs/researchers with great ideas in the life sciences in close collaboration with public and private stakeholders to ensure that these innovations can turn in to solutions which contribute to a healthier society.

Kees Been
Lysosomal Therapeutics Inc.

Erik van de Berg
AM-Pharma

René Bernards
Qameleon Therapeutics & NKI

Annelien Bredenoord
UMC Utrecht

Carine van den Brink
AXON Lawyers

Danielle Curfs
Chemelot InSciTe
Jenny Dankelman
TU Delft
Diederik Dippel
Erasmus MC

Cornelia van Duijn
Erasmus MC

Lude Franke
UMCG
Thibault Helleputte
DNAlytics
Mark van Houdenhoven
St. Maartenskliniek
Henk Joos
Flanders Bio
Peter de Keizer
UMC Utrecht
Tim Knotnerus
AM-Pharma, PRIMER Professionals
Angus Livingstone
Oncode Institute
Travis McCready
Massachusetts Life Sciences Center

Mirjam Mol
Pivot Park

Barend Mons
DTL & LUMC
Timothy Noël
Eindhoven University of Technology
Jacquelien Noordhoek
Dutch CF Foundation
Violet Petit-Steeghs
Athena Institute
Thomas Plochg
NPHF

Gerard van Oortmerssen
Patientenplatform Sancomen

Anne Portwich
LSP
Elisabeth van Rossum
Erasmus MC
André van de Sande
Xendo
Marlies Schijven
AMC
Hans Schikan
Topsector LSH
Hanneke Schuitemaker
Janssen Vaccines
Frits Schut
V.O. Patents & Trademarks
Marieke Schuurmans
UMC Utrecht
Jacob Seidell
VU
Agaath Sluijter
Medical Delta
Thijs Spigt
Erasmus MC
Marianne van der Steen
Maastricht University
Maarten Steinbuch
Eindhoven University of Technology
Onno van de Stolpe
Galapagos
Werner Verbiest
Janssen Diagnostics
Martine de Vries
LUMC

Edward van Wezel
BioGeneration Ventures

Jan van de Winkel
Genmab

Loek Winter
DC Klinieken

Hanneke Heeres
Health~Holland
Caroline Duterloo
Medical Delta
Paul Korte
Janssen
Aart Jan van der Lelij
Erasmus MC
Werner Brouwer
Erasmus University
Arnout van Diermen
Novo Nordisk

Ton van der Steen
Erasmus MC & Medical Delta

Sven de Langen
Gemeente Rotterdam
Sponsors & Partners 2018
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
Award sponsor
© 2018 Innovation for Health